Table 3.
Author, year | Country | Age, yrs | Sex | Propofol |
Latency | Treatment of AP | Follow-up | Outcome | Naranjo scale | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Indication | Duration | Total dose, mg | |||||||||
Leisure et al., 1996 [1] | USA | 34 | Male | Induction of anesthesia | 65 min | 200 | 24 h | Supportive | NR | Recovery | 5 (probable) |
43 | Male | Induction of anesthesia | NR | NRa | few d | Supportive | NR | Recovery | 5 (probable) | ||
77 | Female | Induction of anesthesia | NR | 100 | 1–2 d | Artificial ventilation | Death | Death | 4 (possible) | ||
58 | Female | Induction of anesthesia | NR | 150 | 1–2 d | Hemodialysis | Death | Death | 4 (possible) | ||
Metkus et al., 1996 [22] | USA | 34 | Female | Sedation | 69 d | NRb | 69 d | Drainage of fluid | 330 d | Recovery | 5 (probable) |
Fujii et al., 1998 [23] | Japan | 73 | Male | Induction of anesthesia | 140 min | 100 | 1 d | Supportive | NR | Recovery | 5 (probable) |
Şentürk and Kerman, 1999 [24] | Turkey | 60 | Male | Induction of anesthesia | 140 min | 200 | 2 d | Supportive | 10 d | Recovery | 5 (probable) |
Bird and Brim, 2000 [25] | UK | 34 | Male | Induction of anesthesia | 15 min | 200 | 1 d | Supportive | 7 d | Recovery | 5 (probable) |
Betrosian et al., 2001[26] | Denmark | 35 | Male | Induction + maintenance | 15 min | 140 | few h | Hemodialysis | 21 d | Recovery | 7 (probable) |
Jawaid et al., 2002 [20] | USA | 21 | Female | Induction of anesthesia | 138 min | 150 | 1 d | Supportive- antibiotics | 21 d | Recovery | 7 (probable) |
Farina Castro et al., 2002 [27] | Spain | 23 | Male | Sedation | 7 d | 103 750 | 6 d | Supportive | 35 d | Recovery | 5 (probable) |
Manfredi et al., 2004 [21] | Italy | 27 | Female | Sedation | 60 h | 600 | 3 d | Supportive-octreotide | 19 d | Recovery | 7 (probable) |
Gottschling et al., 2005 [28] | Germany | 12 | Female | Sedation | 45 min | 235 | 2 h | Intensive care | NR | Recovery | 5 (probable) |
Rake et al., 2006 [29] | USA | 12 | Male | Sedation | <24 h | NR | <24 h | Parenteral nutrition | NR | Recovery | 5 (probable) |
Coleman et al., 2006 [16] | USA | 42 | Female | Induction of anesthesia | NR | 300 | 1–2 d | Supportive | > 18 d | Recovery | 5 (probable) |
Gottesman et al., 2007 [30] | USA | 36 | Female | Sedation | NR | NR | 1 d | Supportive | 14 d | Recovery | 7 (probable) |
Tan et al., 2007 [31] | USA | 4 | Female | Induction + maintenance | 60 min | >45c | 10 h | Parenteral nutrition | 30 d | Recovery | 5 (probable) |
Ting and Lee, 2012 [32] | Singapore | 14 | Female | Sedation | 2 d | 5043 | 72 h | Supportive | Death | Deathd | 5 (probable) |
Muniraj and Aslanian, 2012 [33] | USA | 71 | Male | Sedation | 6 d | 8800 | 5 d | Supportive | 17 d | Recovery | 7 (probable) |
Scholten and Buijs, 2014 [3] | Netherlands | 72 | Male | Anesthesia maintenance | few h | 300 | 2–3 h | Supportive | 365 d | Recovery | 7 (probable) |
Csomor et al., 2017 [34] | Czech Republic | 57 | Female | Induction + maintenance | NR | 250 | 15 h | Artificial ventilation, vasopressors, 14 operations | Death | Death | 6 (probable) |
Total: 21 patients | 11 countries | Median35 yrs | 10 males 11 females | Sedation: 8 Anesthesia: 13 | Median 140 min | Median 200 mg | Intermediate: 14 | 20 d | Death: 4 | Possible: 2 Probable: 19 |
AP, acute pancreatitis; NR, not reported; min, minute; h, hour; d, day; yrs, years.
aThe reported dose was 1–1.5 mg/kg without reporting the weight and the duration.
bThe reported dose was 30–140 µg/kg/min for 69 days without reporting patient weight.
cThe total dose was 45 mg for induction and not mentioned for maintenance of anesthesia.
dPatient had viral pneumonia, bacterial tracheitis and septic shock before sedation with propofol and died from bronchopneumonia 12 days after the onset of mild AP onset.